Dose-Dense CHOP plus Rituximab (R-CHOP14) for the Treatment of Elderly Patients with High-Risk Diffuse Large B Cell Lymphoma: A Pilot Study

Publisher： Karger

E-ISSN： 1421-9662|115|1-2|22-27

ISSN： 0001-5792

Source： Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 22-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients

By  

Acta Haematologica, Vol. 136, Iss. 2, 2016-05 ,pp. : 76-84

Karger

Access to resources Recommend Favorite

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R‐CHOP‐14 for elderly patients with diffuse large B‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 787-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot Trial of Systemic Methotrexate plus R-CHOP Regimen with Intrathecal Methotrexate for Simultaneous Central Nervous System and Systemic Diffuse Large B Cell Lymphoma

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 179-182

Karger

Access to resources Recommend Favorite